Bibliographic Details
| Title: |
Cardiac Morpho-Functional Changes, Inflammation and Fibrosis in Systemic Sclerosis—A Pilot Study of a Tertiary Center Cohort. |
| Authors: |
Dorniak, Karolina1 (AUTHOR) kdorniak@gumed.edu.pl, Gogulska, Zuzanna2 (AUTHOR), Viti, Alessandro3 (AUTHOR), Glińska, Anna4 (AUTHOR), Kulawiak-Gałąska, Dorota5 (AUTHOR), Fijałkowska, Jadwiga4 (AUTHOR), Wojteczek, Anna2 (AUTHOR), Wojtowicz, Dagmara1 (AUTHOR), Sienkiewicz, Katarzyna4 (AUTHOR), Hellmann, Marcin1 (AUTHOR), Smoleńska, Żaneta2 (AUTHOR) |
| Source: |
Diagnostics (2075-4418). Feb2025, Vol. 15 Issue 3, p393. 9p. |
| Subject Terms: |
*CARDIAC magnetic resonance imaging, *SYSTEMIC scleroderma, *ECHOCARDIOGRAPHY, *EARLY diagnosis, *SYMPTOMS |
| Abstract: |
Background: Cardiac involvement (CI) in systemic sclerosis (SSc) is frequently subclinical and it can be identified in up to 80% of autopsied hearts. If present, symptoms are related to adverse prognosis, and CI represents one of the predominant causes of SSc-related mortality. Methods: A total of 20 patients with a diagnosis of SSc were included and followed up, and 37 volunteers were included and subsequently scanned on a 1.5T MR system. Results: Overall, thirteen (65%) patients had one or more abnormal cardiac findings in CMR (defined as CI[+]), of which in seven (35%), baseline ECGs and standard echocardiograms were normal or unspecific. Compared to healthy volunteers, SSc patients had a lower LVEF% (56.6% vs. 61.6%; p = 0.0131), longer T1 (1028.3 ms vs. 993.1 ms; p = 0.0049) and T2 relaxation times (48.24 ms vs. 43 ms p = 0.0011), and higher extracellular volume (ECV, 27.9% vs. 26.0%; p = 0.0112). However, no difference in CMR-derived, feature-tracking GLS values between patients and healthy controls was found (−15.5[2,8] vs. −16.3[1,1], respectively, p = 0.11). Over 3.4 (1.9–5.5) years, three patients (15%) died, and two others (10%) sustained major cardiac complications. Conclusions: Cardiac magnetic resonance with modern quantitative techniques reveals subtle morpho-functional alterations and thus allows for early diagnosis of myocardial involvement in systemic sclerosis. Our findings emphasize the need for extended diagnostic workup in these patients and demonstrate the ability of cardiac MR to select patients requiring closer follow-up and/or treatment decisions. [ABSTRACT FROM AUTHOR] |
|
Copyright of Diagnostics (2075-4418) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
